PN HESI Exit Exam Test Bank | 2026/2027 Edition | 150
Verified Questions
PN HESI Exit Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive test bank contains 150 real exam questions from the PN HESI Exit Exam,
designed to prepare nursing students for the HESI PN Exit Exam. Each question includes correct
answers and detailed rationales to reinforce understanding of key concepts. The content is aligned with
the latest NCLEX-PN test plan and HESI guidelines, ensuring relevance for the 2026/2027 academic
year. Ideal for self-assessment and final exam readiness.
Key Features:
150 verified multiple-choice questions with correct answers
Detailed rationales for each answer to explain clinical reasoning
Coverage of all major PN content areas: pharmacology, maternal-child, medical-surgical, psychiatric, and
pediatric nursing
Questions reflect the format and difficulty of the actual HESI PN Exit Exam
Updated to include the latest evidence-based practice and guidelines
Updates for 2026:
- Revised to incorporate 2026 NCLEX-PN test plan changes
- Added new questions on emerging topics such as telehealth and COVID-19 management
- Enhanced rationales with step-by-step clinical reasoning
- Updated drug references to current formulary and safety alerts
- Improved answer formatting for clarity and consistency
Abstract:
The PN HESI Exit Exam Test Bank for the 2026/2027 academic year offers a rigorous preparation tool for nursing
students approaching the HESI PN Exit Exam. This collection of 150 past real exam questions spans all core
domains of practical nursing, including pharmacology, maternal-newborn care, pediatric nursing,
medical-surgical nursing, and psychiatric-mental health nursing. Each question is accompanied by a correct
answer and a comprehensive rationale that elucidates the underlying clinical principles, common errors, and
test-taking strategies. The test bank is meticulously updated to reflect the latest NCLEX-PN test plan and HESI
examination guidelines, ensuring that students encounter current, high-yield content. By engaging with these
questions, learners can identify knowledge gaps, reinforce critical thinking, and build confidence for the actual
exam. The rationales are designed to promote deep understanding rather than rote memorization, making this
resource invaluable for both initial study and final review. This test bank is an essential component of a
comprehensive study plan for achieving a passing score on the HESI PN Exit Exam.
Keywords:
PN HESI Exit Exam, HESI PN test bank, NCLEX-PN preparation, practical nursing exam, 150 questions and
answers, nursing exam rationales, 2026/2027 nursing review
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a detailed rationale explaining why it is correct and why the other options are incorrect. Rationales
include clinical reasoning, relevant pathophysiology, nursing interventions, and test-taking tips to enhance
understanding.
Compliance Checklist:
Page 1
, Aligned with the 2026 NCLEX-PN test plan
Reviewed by subject matter experts for accuracy
Includes rationales that meet educational standards
Covers all major content areas weighted per HESI guidelines
Updated with current evidence-based practice and drug information
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacology 1-30 Drug classifications, dosage calculations, 20%
adverse effects, nursing considerations
Maternal-Newborn Nursing 31-55 Antepartum care, intrapartum care, 17%
postpartum care, newborn assessment
Pediatric Nursing 56-80 Growth and development, common 17%
childhood illnesses, pediatric medication
administration, family-centered care
Medical-Surgical Nursing 81-120 Perioperative care, cardiovascular, 26%
respiratory, gastrointestinal, renal,
endocrine, and musculoskeletal systems
Psychiatric-Mental Health 121-150 Therapeutic communication, mood 20%
Nursing disorders, anxiety disorders, psychotic
disorders, substance abuse
Page 2
,Q1. A patient with chronic kidney disease (CKD) stage 4 is prescribed a low-protein diet. The nurse
understands that this dietary modification primarily aims to:
A. Reduce the workload on the remaining nephrons and delay progression to end-stage renal disease.
B. Prevent hyperkalemia by limiting protein catabolism and intracellular potassium release.
C. Decrease the production of nitrogenous wastes that accumulate in the blood and cause uremic symptoms.
D. Correct metabolic acidosis by reducing the acid load from protein metabolism.
Correct Answer: A. Reduce the workload on the remaining nephrons and delay progression to end-stage
renal disease.
Rationale: In CKD stage 4, the primary goal of a low-protein diet is to reduce glomerular hyperfiltration and
intraglomerular pressure, thereby slowing the decline in renal function. While options B, C, and D are also benefits
of protein restriction, they are secondary to the overarching goal of preserving nephron function and delaying
progression.
Why Wrong:
B - Prevention of hyperkalemia is a benefit but not the primary aim; potassium restriction is managed
separately.
C - Decreasing nitrogenous wastes is a benefit but does not address the underlying mechanism of disease
progression.
D - Reducing acid load is beneficial but not the primary rationale; metabolic acidosis is managed with
bicarbonate if needed.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 54; Lewis, S.L. et al. (2025).
Medical-Surgical Nursing, 11th Ed., Ch. 46.
Q2. A patient receiving a continuous intravenous infusion of heparin develops a platelet count drop from
250,000 to 90,000/mm³ over three days. The nurse anticipates which immediate intervention?
A. Administer protamine sulfate to reverse heparin and switch to fondaparinux.
B. Discontinue heparin immediately and obtain a HIT antibody test.
C. Reduce the heparin infusion rate by 50% and monitor platelets daily.
D. Administer low-molecular-weight heparin as a substitute for unfractionated heparin.
Correct Answer: B. Discontinue heparin immediately and obtain a HIT antibody test.
Rationale: A platelet count drop of >50% from baseline during heparin therapy is indicative of heparin-induced
thrombocytopenia (HIT). The immediate priority is to discontinue all heparin products (including flushes and
heparin-coated catheters) and confirm the diagnosis with HIT antibody testing. Protamine sulfate is used to reverse
heparin in case of bleeding, not for HIT. LMWH is contraindicated due to cross-reactivity.
Why Wrong:
A - Protamine is not indicated for HIT; it reverses heparin's anticoagulant effect but does not address the
immune-mediated thrombocytopenia.
C - Reducing the dose is insufficient; all heparin must be stopped to prevent thrombotic complications.
D - LMWH has a high cross-reactivity rate with HIT antibodies and should not be used as a substitute.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 30; Lewis, S.L. et al. (2025).
Medical-Surgical Nursing, 11th Ed., Ch. 31.
Q3. A patient with a history of heart failure and chronic atrial fibrillation is admitted with acute dyspnea and
oxygen saturation of 88% on room air. The nurse auscultates crackles halfway up the lung fields and notes
jugular venous distention. Which medication should the nurse question if prescribed?
A. Furosemide 40 mg intravenous push
B. Digoxin 0.125 mg orally daily
C. Metoprolol succinate 25 mg orally daily
D. Morphine sulfate 2 mg intravenous push
Correct Answer: C. Metoprolol succinate 25 mg orally daily
Page 3
, Rationale: The patient is in acute decompensated heart failure with pulmonary edema. Beta-blockers, such as metoprolol
succinate, are contraindicated during acute exacerbation because they can worsen hemodynamic status by reducing
myocardial contractility and heart rate. Furosemide, digoxin, and morphine are appropriate for acute management:
furosemide for diuresis, digoxin for rate control in atrial fibrillation, and morphine for preload reduction and anxiety.
Why Wrong:
A - Furosemide is indicated for reducing fluid overload in acute heart failure.
B - Digoxin is appropriate for rate control in atrial fibrillation, especially in heart failure with reduced ejection fraction.
D - Morphine reduces preload and anxiety, which is beneficial in acute pulmonary edema.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 38; Yancy, C.W. et al. (2023). ACC/AHA/HFSA
Guideline for the Management of Heart Failure.
Q4. A patient who underwent a total knee arthroplasty 8 hours ago has a patient-controlled analgesia (PCA)
pump set to deliver morphine 1 mg IV with a 6-minute lockout and a 4-hour limit of 30 mg. The patient
reports pain at 8/10 and has received 12 mg in the past 4 hours. The nurse notes a respiratory rate of 10
breaths/min and sedation score of 3 (moderately drowsy). What is the nurse's priority action?
A. Administer naloxone 0.4 mg IV push immediately.
B. Stop the PCA infusion and administer a non-opioid analgesic.
C. Decrease the PCA dose to 0.5 mg and continue monitoring.
D. Increase the lockout interval to 10 minutes to reduce total dose.
Correct Answer: A. Administer naloxone 0.4 mg IV push immediately.
Rationale: The patient has respiratory depression (RR 10) and sedation, indicating opioid overdose. Naloxone is
indicated to reverse respiratory depression. The dose of 0.4 mg IV is appropriate for emergency reversal. Simply
stopping the PCA or adjusting settings does not address the immediate respiratory compromise. Non-opioid
analgesics are insufficient for acute pain control in this situation.
Why Wrong:
B - Stopping the PCA and using non-opioids does not reverse the respiratory depression already present.
C - Decreasing the dose does not address the current overdose; reversal is needed first.
D - Increasing the lockout interval does not reverse existing respiratory depression.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 14; Pasero, C. & McCaffery, M.
(2024). Pain Assessment and Pharmacologic Management.
Q5. A patient with type 2 diabetes mellitus is started on metformin 500 mg twice daily. Three days later, the
patient reports nausea, diarrhea, and a metallic taste. Which laboratory value is most important for the
nurse to monitor?
A. Serum creatinine and BUN
B. Hemoglobin A1C
C. Fasting blood glucose
D. Liver function tests
Correct Answer: A. Serum creatinine and BUN
Rationale: Metformin is contraindicated in renal impairment (eGFR <30 mL/min) due to the risk of lactic acidosis.
The gastrointestinal side effects are common initially, but renal function must be assessed before continuing
therapy. Hemoglobin A1C and fasting glucose are relevant for efficacy but not for immediate safety. Liver function
tests are not specifically required for metformin monitoring.
Why Wrong:
B - Hemoglobin A1C reflects long-term glucose control and is not used to monitor acute metformin safety.
C - Fasting blood glucose is important for diabetes management but does not assess renal function or risk of
lactic acidosis.
D - Liver function tests are not routinely monitored with metformin; renal function is the priority.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 45; American Diabetes Association
Page 4
Verified Questions
PN HESI Exit Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive test bank contains 150 real exam questions from the PN HESI Exit Exam,
designed to prepare nursing students for the HESI PN Exit Exam. Each question includes correct
answers and detailed rationales to reinforce understanding of key concepts. The content is aligned with
the latest NCLEX-PN test plan and HESI guidelines, ensuring relevance for the 2026/2027 academic
year. Ideal for self-assessment and final exam readiness.
Key Features:
150 verified multiple-choice questions with correct answers
Detailed rationales for each answer to explain clinical reasoning
Coverage of all major PN content areas: pharmacology, maternal-child, medical-surgical, psychiatric, and
pediatric nursing
Questions reflect the format and difficulty of the actual HESI PN Exit Exam
Updated to include the latest evidence-based practice and guidelines
Updates for 2026:
- Revised to incorporate 2026 NCLEX-PN test plan changes
- Added new questions on emerging topics such as telehealth and COVID-19 management
- Enhanced rationales with step-by-step clinical reasoning
- Updated drug references to current formulary and safety alerts
- Improved answer formatting for clarity and consistency
Abstract:
The PN HESI Exit Exam Test Bank for the 2026/2027 academic year offers a rigorous preparation tool for nursing
students approaching the HESI PN Exit Exam. This collection of 150 past real exam questions spans all core
domains of practical nursing, including pharmacology, maternal-newborn care, pediatric nursing,
medical-surgical nursing, and psychiatric-mental health nursing. Each question is accompanied by a correct
answer and a comprehensive rationale that elucidates the underlying clinical principles, common errors, and
test-taking strategies. The test bank is meticulously updated to reflect the latest NCLEX-PN test plan and HESI
examination guidelines, ensuring that students encounter current, high-yield content. By engaging with these
questions, learners can identify knowledge gaps, reinforce critical thinking, and build confidence for the actual
exam. The rationales are designed to promote deep understanding rather than rote memorization, making this
resource invaluable for both initial study and final review. This test bank is an essential component of a
comprehensive study plan for achieving a passing score on the HESI PN Exit Exam.
Keywords:
PN HESI Exit Exam, HESI PN test bank, NCLEX-PN preparation, practical nursing exam, 150 questions and
answers, nursing exam rationales, 2026/2027 nursing review
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a detailed rationale explaining why it is correct and why the other options are incorrect. Rationales
include clinical reasoning, relevant pathophysiology, nursing interventions, and test-taking tips to enhance
understanding.
Compliance Checklist:
Page 1
, Aligned with the 2026 NCLEX-PN test plan
Reviewed by subject matter experts for accuracy
Includes rationales that meet educational standards
Covers all major content areas weighted per HESI guidelines
Updated with current evidence-based practice and drug information
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacology 1-30 Drug classifications, dosage calculations, 20%
adverse effects, nursing considerations
Maternal-Newborn Nursing 31-55 Antepartum care, intrapartum care, 17%
postpartum care, newborn assessment
Pediatric Nursing 56-80 Growth and development, common 17%
childhood illnesses, pediatric medication
administration, family-centered care
Medical-Surgical Nursing 81-120 Perioperative care, cardiovascular, 26%
respiratory, gastrointestinal, renal,
endocrine, and musculoskeletal systems
Psychiatric-Mental Health 121-150 Therapeutic communication, mood 20%
Nursing disorders, anxiety disorders, psychotic
disorders, substance abuse
Page 2
,Q1. A patient with chronic kidney disease (CKD) stage 4 is prescribed a low-protein diet. The nurse
understands that this dietary modification primarily aims to:
A. Reduce the workload on the remaining nephrons and delay progression to end-stage renal disease.
B. Prevent hyperkalemia by limiting protein catabolism and intracellular potassium release.
C. Decrease the production of nitrogenous wastes that accumulate in the blood and cause uremic symptoms.
D. Correct metabolic acidosis by reducing the acid load from protein metabolism.
Correct Answer: A. Reduce the workload on the remaining nephrons and delay progression to end-stage
renal disease.
Rationale: In CKD stage 4, the primary goal of a low-protein diet is to reduce glomerular hyperfiltration and
intraglomerular pressure, thereby slowing the decline in renal function. While options B, C, and D are also benefits
of protein restriction, they are secondary to the overarching goal of preserving nephron function and delaying
progression.
Why Wrong:
B - Prevention of hyperkalemia is a benefit but not the primary aim; potassium restriction is managed
separately.
C - Decreasing nitrogenous wastes is a benefit but does not address the underlying mechanism of disease
progression.
D - Reducing acid load is beneficial but not the primary rationale; metabolic acidosis is managed with
bicarbonate if needed.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 54; Lewis, S.L. et al. (2025).
Medical-Surgical Nursing, 11th Ed., Ch. 46.
Q2. A patient receiving a continuous intravenous infusion of heparin develops a platelet count drop from
250,000 to 90,000/mm³ over three days. The nurse anticipates which immediate intervention?
A. Administer protamine sulfate to reverse heparin and switch to fondaparinux.
B. Discontinue heparin immediately and obtain a HIT antibody test.
C. Reduce the heparin infusion rate by 50% and monitor platelets daily.
D. Administer low-molecular-weight heparin as a substitute for unfractionated heparin.
Correct Answer: B. Discontinue heparin immediately and obtain a HIT antibody test.
Rationale: A platelet count drop of >50% from baseline during heparin therapy is indicative of heparin-induced
thrombocytopenia (HIT). The immediate priority is to discontinue all heparin products (including flushes and
heparin-coated catheters) and confirm the diagnosis with HIT antibody testing. Protamine sulfate is used to reverse
heparin in case of bleeding, not for HIT. LMWH is contraindicated due to cross-reactivity.
Why Wrong:
A - Protamine is not indicated for HIT; it reverses heparin's anticoagulant effect but does not address the
immune-mediated thrombocytopenia.
C - Reducing the dose is insufficient; all heparin must be stopped to prevent thrombotic complications.
D - LMWH has a high cross-reactivity rate with HIT antibodies and should not be used as a substitute.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 30; Lewis, S.L. et al. (2025).
Medical-Surgical Nursing, 11th Ed., Ch. 31.
Q3. A patient with a history of heart failure and chronic atrial fibrillation is admitted with acute dyspnea and
oxygen saturation of 88% on room air. The nurse auscultates crackles halfway up the lung fields and notes
jugular venous distention. Which medication should the nurse question if prescribed?
A. Furosemide 40 mg intravenous push
B. Digoxin 0.125 mg orally daily
C. Metoprolol succinate 25 mg orally daily
D. Morphine sulfate 2 mg intravenous push
Correct Answer: C. Metoprolol succinate 25 mg orally daily
Page 3
, Rationale: The patient is in acute decompensated heart failure with pulmonary edema. Beta-blockers, such as metoprolol
succinate, are contraindicated during acute exacerbation because they can worsen hemodynamic status by reducing
myocardial contractility and heart rate. Furosemide, digoxin, and morphine are appropriate for acute management:
furosemide for diuresis, digoxin for rate control in atrial fibrillation, and morphine for preload reduction and anxiety.
Why Wrong:
A - Furosemide is indicated for reducing fluid overload in acute heart failure.
B - Digoxin is appropriate for rate control in atrial fibrillation, especially in heart failure with reduced ejection fraction.
D - Morphine reduces preload and anxiety, which is beneficial in acute pulmonary edema.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 38; Yancy, C.W. et al. (2023). ACC/AHA/HFSA
Guideline for the Management of Heart Failure.
Q4. A patient who underwent a total knee arthroplasty 8 hours ago has a patient-controlled analgesia (PCA)
pump set to deliver morphine 1 mg IV with a 6-minute lockout and a 4-hour limit of 30 mg. The patient
reports pain at 8/10 and has received 12 mg in the past 4 hours. The nurse notes a respiratory rate of 10
breaths/min and sedation score of 3 (moderately drowsy). What is the nurse's priority action?
A. Administer naloxone 0.4 mg IV push immediately.
B. Stop the PCA infusion and administer a non-opioid analgesic.
C. Decrease the PCA dose to 0.5 mg and continue monitoring.
D. Increase the lockout interval to 10 minutes to reduce total dose.
Correct Answer: A. Administer naloxone 0.4 mg IV push immediately.
Rationale: The patient has respiratory depression (RR 10) and sedation, indicating opioid overdose. Naloxone is
indicated to reverse respiratory depression. The dose of 0.4 mg IV is appropriate for emergency reversal. Simply
stopping the PCA or adjusting settings does not address the immediate respiratory compromise. Non-opioid
analgesics are insufficient for acute pain control in this situation.
Why Wrong:
B - Stopping the PCA and using non-opioids does not reverse the respiratory depression already present.
C - Decreasing the dose does not address the current overdose; reversal is needed first.
D - Increasing the lockout interval does not reverse existing respiratory depression.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 14; Pasero, C. & McCaffery, M.
(2024). Pain Assessment and Pharmacologic Management.
Q5. A patient with type 2 diabetes mellitus is started on metformin 500 mg twice daily. Three days later, the
patient reports nausea, diarrhea, and a metallic taste. Which laboratory value is most important for the
nurse to monitor?
A. Serum creatinine and BUN
B. Hemoglobin A1C
C. Fasting blood glucose
D. Liver function tests
Correct Answer: A. Serum creatinine and BUN
Rationale: Metformin is contraindicated in renal impairment (eGFR <30 mL/min) due to the risk of lactic acidosis.
The gastrointestinal side effects are common initially, but renal function must be assessed before continuing
therapy. Hemoglobin A1C and fasting glucose are relevant for efficacy but not for immediate safety. Liver function
tests are not specifically required for metformin monitoring.
Why Wrong:
B - Hemoglobin A1C reflects long-term glucose control and is not used to monitor acute metformin safety.
C - Fasting blood glucose is important for diabetes management but does not assess renal function or risk of
lactic acidosis.
D - Liver function tests are not routinely monitored with metformin; renal function is the priority.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 45; American Diabetes Association
Page 4
